Climb Bio (CLYM) Change in Account Payables (2020 - 2026)

Climb Bio (CLYM) has 7 years of Change in Account Payables data on file, last reported at -$1.4 million in Q1 2026.

• Quarterly Change in Account Payables fell 2056.94% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83000.0 (up 109.11% YoY) and the FY2025 annual result came in at $1.6 million, up 262.41% from the prior year.
• Change in Account Payables retreated to -$1.4 million in Q1 2026, from $1.8 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.8 million in Q4 2025 to a low of -$1.4 million in Q1 2026.
• A 5-year average of -$126294.1 and a median of $14000.0 in 2023 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables surged 608.7% — and 2024, when it tumbled 8528.57%.
• Tracing CLYM's Change in Account Payables over 5 years: stood at -$744000.0 in 2022, then increased by 9.68% to -$672000.0 in 2023, then jumped by 161.61% to $414000.0 in 2024, then surged by 332.85% to $1.8 million in 2025, then tumbled by 178.63% to -$1.4 million in 2026.
• The last three Change in Account Payables figures came in at -$1.4 million (Q1 2026), $1.8 million (Q4 2025), and -$393000.0 (Q3 2025), per Business Quant data.